Table 4: Prescribed antimalarial drugs in uncomplicated malaria treatment per study sites.
|
Prescribed antimalarial drugs |
Location (n = 300) |
Total n (%) |
|
|
Bougouni n (%) |
Kangaba n (%) |
||
|
Artemether lumfantrine (tablet) |
41 (45.6) |
69 (32.9) |
110 (36.7) |
|
Artemether (injection) |
11 (12.2) |
101 (48.1) |
112 (37.3) |
|
Quinine (tablet) |
13 (14.4) |
17 (8.1) |
30 (10) |
|
Quinine (injection) |
13 (14.4) |
11 (5.2) |
24 (8) |
|
Artemether (syrup) |
5 (5.6) |
9 (4.3) |
14 (4.7) |
|
Artersunate (injection) |
1 (1.1) |
3 (1.4) |
4 (1.3) |
|
Sulfadoxine-Pyrimethamine (tablet) |
2 (2.2) |
0 (0) |
2 (0.7) |
|
Amodiaquine (syrup) |
1 (1.1) |
0 (0) |
1 (0.3) |
|
Artesunate-Amodiaquine (tablet) |
1 (1.1) |
0 (0) |
1 (0.3) |
|
Other ACTs |
2 (2.2) |
0 (0) |
2 (0.7) |
|
TOTAL |
9 (100) |
210 (100) |
300 (100) |